Approval · Notice of Compliance 5886 · 1994
SANTYL: Notice of Compliance 5886
Issued March 25, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5886
- Date
- March 25, 1994
- Company
- Knoll Pharma Inc.Markham, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Enzymatic debriding agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SANTYL | 02063670 | Cancelled Post Market |
Medicinal ingredients
- COLLAGENASE 250 UNIT per G